Author:
Titov V. N.,Rozhkova T. A.,Aripovsky A. V.
Publisher
LLC Obyedinennaya Redaktsiya
Subject
General Medicine,Endocrinology, Diabetes and Metabolism,History,Family Practice
Reference42 articles.
1. Antonopoulos AS, Margaritis M, Lee R, Channon K, Antoniades C. Statins as anti-inflammatory agents in atherogenesis: molecular mechanisms and lessons from the recent clinical trials. Curr Pharmceut Des. 2012;18:1519-1530.
2. Titov V.N. Filogeneticheskaya teoriya stanovleniya bolezni, teoriya patologii, patogenez «metabolicheskikh pandemii» i rol' klinicheskoi biokhimii. Klinicheskaya laboratornaya diagnostika. 2012;10:5-13.
3. Boden WE, Sidhu MS, Toth PP. The therapeutic role of niacin in dyslipidemia management. J Cardiovasc Pharmacol Ther. 2014; 19(2):141-158.
4. Zhang LH, Kamanna VS, Ganji SH. Xiong XM, Kashyap ML. Niacin increases HDL biogenesis by enhancing DR4-dependent transcription of ABCA1 and lipidation of apolipoprotein A-I in HepG2 cells. J Lipid Res. 2012;53:941-950.
5. Lopez-Miranda J, Williams C, Lairon D. Dietary, physiological, genetic and pathological influences on postprandial lipid metabolism. Br J Nutr. 2007;98:458-473.